Featured
-
-
Short Communication
| Open AccessSkeletal muscle anabolism is a side effect of therapy with the MEK inhibitor: selumetinib in patients with cholangiocarcinoma
- C M M Prado
- , T Bekaii-Saab
- & M B Sawyer
-
Mini Review
| Open AccessInfluence of eicosapentaenoic acid supplementation on lean body mass in cancer cachexia
- R A Murphy
- , E Yeung
- & M Mourtzakis